Evidence map›Paper›PMID 21345249›Full record

ArticleArthritis research & therapy2011

Molecular targets of natural health products in arthritis.

Sarah Khalifé, Muhammad Zafarullah

Open access · goldAbstract readEditorial
In one paragraph

Article in Arthritis research & therapy, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 28 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Amyotrophic Lateral Sclerosis: A Diet Review.Foods (Basel, Switzerland) · 2021
    Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Harpagoside suppresses IL-6 expression in primary human osteoarthritis chondrocytes.Journal of orthopaedic research : official publication of the Orthopaedic Research Society · 2017
    Article
  10. Article
  11. Article
  12. Article
  13. Immunopathogenesis of osteoarthritis.Clinical immunology (Orlando, Fla.) · 2013
    Review
  14. Article
  15. Current nutraceuticals in the management of osteoarthritis: a review.Therapeutic advances in musculoskeletal disease · 2012
    Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Sarah Khalifé
Muhammad Zafarullah
Hôpital Notre-Dame · CA

Funding

Canadian Institutes of Health Research
6 · The paper itself

Abstract

Patients with rheumatoid arthritis (RA) and osteoarthritis (OA) consume 'natural health products' (NHPs) whose therapeutic efficacy, toxicity and mechanisms of action are poorly understood. In a previous issue of Arthritis Research and Therapy, Haqqi and colleagues characterized IL-1-activated mitogen-activated protein kinase kinase 3 (MKK3) and p38-mitogen-activated protein kinase (MAPK) isoforms in human OA chondrocytes. The cartilageprotective mechanisms of pomegranate extract involve diminishing MKK3-activated p38α, JNK, NF-κB and Runx2 pathways, which regulate inflammatory proteins and cartilage-destroying proteases. Epigallocatechin- 3-gallate, resveratrol, curcumin and other NHP active ingredients suppress multiple inflammatory and catabolic molecular mediators of arthritis. Non-toxicity, reduced severity and incidence of arthritis in animal models warrant testing NHP active ingredients for preventing human OA and RA.

Indexed as

Food, OrganicAnimalsAnti-Inflammatory AgentsAntioxidantsArthritisComplementary TherapiesHumansAnti-Inflammatory AgentsAntioxidants

Identifiers

PMID21345249
PMCPMC3157637
OpenAlexW2161060506

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.